1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Toripalimab-tpzi: new trials by email Literature Review of Toripalimab-tpzi trials Research Report on Toripalimab-tpzi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma TMV Vaccine, Toripalimab-tpzi - Squamous Cell Carcinoma of Head and Neck, Squamous Cell Carcinoma of Head and Neck (SCCHN) | Phase 1 | Recruiting | Metaclipse Therapeutics Corporation | 30 | 2026-10-01 | 2026-10-27 |
| A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors CHS-1000, Toripalimab - Advanced or Metastatic Solid Tumors | Phase 1 | Not yet recruiting | Coherus Oncology, Inc. | 48 | 2025-02-15 | 2024-09-19 |
| Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy Atezolizumab, Avelumab, Cemiplimab - Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin Neoplasm | Phase 1 | Active not recruiting | University of Southern California | 10 | 2020-08-12 | 2026-09-21 |
Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Neoplasm Recurrence, Local (1) · Neoplasms (1) · Oropharyngeal Neoplasms (1) · Skin Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Coherus Oncology, Inc. (1) · Metaclipse Therapeutics Corporation (1) · University of Southern California (1)
United States (2)
Christopher Pack, PhD (1) · Gino K In, MD (1) · Kristen Jacobsen, PhD (1) · Michael Coleman, PhD (1) · Periasamy Selvaraj, PhD (1)
P30CA014089 (1)